Their Berkeley Lights Platform captures detailed information from thousands of single cells, enabling rapid functional characterization and the selection of the best cells for biotherapeutic development. The platform includes proprietary consumables, automation systems, and software, and is used in various fields such as antibody discovery, cell therapy development, and synthetic biology. During the COVID-19 pandemic, researchers utilized the company's Beacon platform to guide and isolate cells for discovering antibodies. Berkeley Lights operates globally, with North America being its largest revenue source.